Showing results (1241-1250 of 1,274) with videos related to
Sort By:
Pageof 128
Journal of the National Cancer Institute|November 6, 1996
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study complianceD Albanes, O P Heinonen, P R Taylor, et al.JAMA Network Open|June 3, 2025
Estimated Burden of CoccidioidomycosisSamantha L Williams, Kaitlin Benedict, Brendan R Jackson, et al.Developmental Cell|August 15, 2023
Single-cell census of human tooth development enables generation of human enamelAmmar Alghadeer, Sesha Hanson-Drury, Anjali P Patni, et al.Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.Eclinicalmedicine|November 25, 2020
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulationKfir Oved, Liraz Olmer, Yonat Shemer-Avni, et al.Blood|June 22, 2021
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E Horwitz, Patrick J Stiff, Corey Cutler, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit TransplantationPatrick J Stiff, Pau Montesinos, Tony Peled, et al.Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.Blood|April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Yi-Bin Chen, Robert A Redd, et al.Pageof 128